Companies › GNPX

Genprex Inc (GNPX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001595248 · EDGAR filings · Updated 2026-07-14

Genprex Inc (GNPX) has reported institutional ownership of 1.0%, with 27 institutional managers holding positions valued at $169.0K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-14 — Current report (8-K) filed
• 2026-06-26 — Employee-plan registration (S-8) filed
• 2026-06-22 — Current report (8-K) filed
• 2026-06-18 — Current report (8-K) filed
• 2026-06-12 — Current report (8-K) filed
• 2026-06-05 — Shelf registration (S-3) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Genprex Inc has 27 institutional holders and institutional ownership of 1.0%.

Insider activity

Insiders reported 9 transactions (0 buys, 0 sells) across 5 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

ENvue Medical Inc (FEED) · MATINAS BIOPHARMA HLDGS INC (MTNB) · XTL BIOPHARMACEUTICALS LTD (XTLB) · CURANEX PHARMACEUTICALS INC (CURX) · HCW Biologics Inc (HCWB) · SONOMA PHARMACEUTICALS INC (SNOA)